Friday, 17 Aug 2018

You are here

The RheumNow Week in Review - 23 February 2018

Dr Jack Cush reviews highlights from the past week on RheumNow.com. This week’s video is in two parts; for part Ii, go to https://buff.ly/2BM9MjL

  1. Duke Federico of Montefeltro (1422-1482) shown to have #gout based on letters and examination of skeletal remains. Gout was alive and active during the Italian Renaissance. https://t.co/yNnYWZlU5G
  2. Gout management by UK Rheums conform to guidelines, yet ~45% reach target SUA<6.0.  Study of 4343 Gout pts; 82% M; 13% crystal-proven. 29% stopped diuretic, 76% on ULT; prophylaxis was co-prescribed for 94%. https://buff.ly/2F0yLlA
  3. FDA grants "breakthrough" status to Pfizers Xeljanz (tofacitinib) for phase III trials in atopic dermatitis https://t.co/hzdMTjxmg1
  4. Dr. Hyman Zimmerman is famous for drug-induced hepatocellular injury plus jaundice conferring a 10% mortality rate. "Hy's Law" is used by the FDA to judge serious hepatotoxicity and risk of death; Requires evidence of jaundice and ALT/AST >3x ULN https://t.co/qu65fdGscf
  5. Australian study shows ACL injuries in children  have increased 148% in 10 yrs (2.74 per 100,000 2005 to 6.79 per 100,000 in 2015). US pediatricians have also reported increases in ACL tears in children/teens. https://t.co/Z5m2vQvlEk
  6. PANTS study: Personalized anti-TNF Therapy in Crohn Disease tests real-world eficacy, safety & immunogenicity of infliximab vs biosimilar CT- P13 vs adalimumab. Wk 54 remission rate was 40% INFX, 40% CTP13 & 34% in ADA; immunogenicity was 26%, 28%, 11% https://t.co/irhImH6ipP
  7. 3 decade study from Mayo clinic shows the incidence of symptomatic and asymptomatic renal stones increased 14-29% per 5 years in men and women https://t.co/yMmsQkxxHx
  8. Dentists are ill at ease providing dental surgery to patients on bisphosphonates. 63% active ask about BP Rx, 85% reluctant to do dental surgery if on BP Rx. https://t.co/pkmuvKGMT3
  9. Oral Anticoagulation Effective Following Hip and Knee Replacement Surgery  
  10. Are ANA Tests Unreliable 
  11. Pediatric Use of TNF inhbitors Does Not Increase Malignancy Risk  
  12. HERO Trial - Hydroxychloroquine Fails in Hand Osteoarthritis 
  13. Apremilast Continues to Look Good in Behcet's Disease 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

ACR Meets With HHS Secretary Azar to Discuss Step Therapy Concerns

Yesterday, the American College of Rheumatology (ACR) met with U.S. Department of Health and Human Services Secretary Alex Azar for a productive discussion about the rheumatology community's concerns with a new policy that will allow Medicare Advantage plans to utilize step therapy in Medicare Part B. In the meeting, the ACR expressed concerns that this policy would delay rheumatology patients' access to treatments.

The RheumNow Week in Review – We’re Number One! (8.17.18)

Dr. Cush reviews the articles and news from the last week on RheumNow.com. Information on comorbidities, the downside of steroids, unmet need in psoriatic arthritis, and the top 10 rheumatology programs.

U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

The RheumNow Week in Review – No Good Gout (8.10.18)

Dr. Jack Cush reviews the news and latest journal articles from the past week on RheumNow.com. Info on Surgery and Hip Fractures, Gout drugs abandoned, Allopurinol escalation, hydroxychloroquine drug levels, how to treat scleroderma in India and exactly who gets back pain.

The RheumNow Week in Review – Handshakes or Hugs (8.3.18)

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com, including new treatments for LTBI, gout consequences, RA and offspring risk, PsA risk, and the opioid epidemic effects.